The USPTO recently introduced its initiative to "fast track" patent applications which cover immunotherapies for cancer. The program is designed to support the White House's National Cancer Moonshot, which aims to eliminate cancer with a $1 Billion call to arms to find new therapies and techniques for prevention. Eligible applications will be prioritized for examination, and, once accepted into the program, applicants can expect to receive a final decision in one year or less.
USPTO Launches Pilot Program for Cancer Immunotherapy ApplicationsWritten by W. John Eagan
Mr. Eagan earned his bachelor’s degree in Mechanical Engineering from Lehigh University and his law degree, with honors from the University of Miami. While at the University of Miami he served as the Inter-American Citator and an Articles and Comments Editor for the Inter-American Law Review. Mr. Eagan is admitted to practice law in the State of Florida and concentrates his practice in Intellectual Property litigation.
Latest from W. John Eagan
- Apple Avoids $300 Million Patent Infringement Verdict
- USPTO Publishes Proposed Rules Implementing Trademark Modernization Act
- U.S. Patent No. 11,000,000
- U.S. Trade Representative Signals Support for Waiver of COVID-19 Vaccine IP Rights
- Declarations of Use Required for Mexican Trademark Registrations